These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 797547)

  • 21. Discoid lupus erythematosus. Diagnostic features and evaluation of topical corticosteroid therapy.
    Roenigk HH; Martin JS; Eichorn P; Gilliam JN
    Cutis; 1980 Mar; 25(3):281-5. PubMed ID: 6987043
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of a polyester fiber sponge as an adjunct in the treatment of psoriasis.
    Shellow WV
    Cutis; 1978 Mar; 21(3):415-7. PubMed ID: 630919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.
    Lee CS; Koo J
    J Drugs Dermatol; 2009 Aug; 8(8):751-5. PubMed ID: 19663113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment.
    Clark RF; Clement ER
    Arch Dermatol; 1975 Jun; 111(6):731-3. PubMed ID: 1094960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of non-inflammatory dermatoses. A double-blind comparison of 1% hydrocortisone plus 10% urea and 0.05% fluocinonide.
    Khan SA
    Practitioner; 1978 Aug; 221(1322):265-7. PubMed ID: 364458
    [No Abstract]   [Full Text] [Related]  

  • 26. Systemic effects of topical application of beclomethasone 17,21-dipropionate: comparative studies with betamethasone 17-valerate ointment and fluocinonide cream.
    Shimao S
    J Dermatol; 1979 Dec; 6(6):383-90. PubMed ID: 396316
    [No Abstract]   [Full Text] [Related]  

  • 27. Multicenter trial analysis. Fluocinonide and betamethasone gel in psoriasis.
    Barsky S
    Arch Dermatol; 1976 Dec; 112(12):1729-33. PubMed ID: 795379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of psoriasis with triamcinolone acetonide 0.1% under occlusion: a comparison of two hydrocolloid dressings.
    González JR; Cabán F
    Bol Asoc Med P R; 1990 Jul; 82(7):288-91. PubMed ID: 2261015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A trial of the Actiderm dermatological patch and topical corticosteroids in the treatment of psoriasis vulgaris. The Actiderm Multi-Center Study Group.
    Cutis; 1990 Jul; 46(1):84-8. PubMed ID: 2200652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A double-blind clinical trial of fluocinonide and betamethasone valerate in psoriasis].
    Feuerman E
    Harefuah; 1974 Jul; 87(2):59-60. PubMed ID: 4605470
    [No Abstract]   [Full Text] [Related]  

  • 31. Pituitary-adrenal function following topical triamcinolone acetonide and occlusion.
    Taylor KS; Malkinson FD; Gak C
    Arch Dermatol; 1965 Aug; 92(2):174-7. PubMed ID: 11850923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasis.
    Ellis CN; Katz HI; Rex IH; Shavin JS; Van Scott EJ; VanderPloeg D
    Clin Ther; 1989; 11(6):768-74. PubMed ID: 2692821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical fluocinonide and tachyphylaxis.
    Senter TP
    Arch Dermatol; 1983 May; 119(5):363-4. PubMed ID: 6847210
    [No Abstract]   [Full Text] [Related]  

  • 34. Diflorasone diacetate: vasoconstrictor activity and clinical efficacy of a new topical corticosteroid.
    Bluefarb SM; Howard FM; Leibsohn E; Schlagel CA; Wexler L
    J Int Med Res; 1976; 4(6):454-61. PubMed ID: 800385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical assessment of topical corticosteroid activity.
    Wilson L
    Br J Dermatol; 1976 Mar; 94 suppl 12():33-42. PubMed ID: 773412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topically applied fluocinonide in an adhesive base in the treatment of oral vesiculoerosive diseases.
    Lozada F; Silverman S
    Arch Dermatol; 1980 Aug; 116(8):898-901. PubMed ID: 6996618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A hydrocolloid occlusive dressing plus triamcinolone acetonide cream is superior to clobetasol cream in palmo-plantar pustulosis.
    Kragballe K; Larsen FG
    Acta Derm Venereol; 1991; 71(6):540-2. PubMed ID: 1685841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled clinical trial of the efficacy of topically applied fluocinonide in the treatment of recurrent aphthous ulceration.
    Pimlott SJ; Walker DM
    Br Dent J; 1983 Mar; 154(6):174-7. PubMed ID: 6342633
    [No Abstract]   [Full Text] [Related]  

  • 39. Psoriasis therapy: comparative studies with a hydrocolloid dressing, plastic film occlusion, and triamcinolone acetonide cream.
    David M; Lowe NJ
    J Am Acad Dermatol; 1989 Sep; 21(3 Pt 1):511-4. PubMed ID: 2778112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenal suppression with high-potency corticosteroid ointment formulations in normal subjects.
    Novak E; Francom SF; Schlagel CA
    Clin Ther; 1983; 6(1):59-71. PubMed ID: 6370438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.